Please enable JavaScript to continue using this application.

Compare $CADL vs $IMUX | Chartloom

Compare

$CADL vs $IMUX

Candel Therapeutics Inc · Immunic Inc

CADL

Candel Therapeutics Inc

IMUX

Immunic Inc

Compare $CADL vs $IMUX

Comparing Candel Therapeutics Inc and Immunic Inc

CADLCandel Therapeutics Inc

IMUXImmunic Inc

CADLCandel Therapeutics Inc

Market cap

$728M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

82.7%

52W performance

57.8%

FCF yield

-7.9%

IMUXImmunic Inc

Market cap

$112M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

40.5%

52W performance

-8.8%

FCF yield

-78.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CADL

IMUX

Detailed metrics comparison

CADL

Candel Therapeutics Inc

IMUX

Immunic Inc

Market Cap

CADL$728M

IMUX$112M

Enterprise Value

CADL$575M

IMUX$-44M

Price

CADL$9.94

IMUX$8.19

P/E Ratio

CADLN/A

IMUXN/A

P/S Ratio

CADL6,281.93x

IMUX0.00x

EV/Sales

CADL5,042.14x

IMUX0.00x

EV/EBITDA

CADL0.00x

IMUX0.00x

P/B Ratio

CADL6.18x

IMUX0.85x

P/FCF Ratio

CADLN/A

IMUXN/A

EV/FCF

CADL-10.02x

IMUX0.49x

PEG Ratio

CADLN/A

IMUXN/A

Forward P/E (NTM)

CADLN/A

IMUXN/A

Forward P/S (NTM)

CADLN/A

IMUXN/A

Revenue (TTM)

CADL$0

IMUX$0

Revenue Growth (YoY)

CADLN/A

IMUXN/A

Forward Rev Growth

CADL371.1%

IMUX650.4%

Gross Margin (TTM)

CADL0.0%

IMUX0.0%

Operating Margin (TTM)

CADL0.0%

IMUX0.0%

EBITDA Margin (TTM)

CADL0.0%

IMUX0.0%

Net Margin (TTM)

CADL0.0%

IMUX0.0%

FCF Margin (TTM)

CADLN/A

IMUXN/A

Net Income (TTM)

CADL$-89M

IMUX$-112M

FCF (TTM)

CADL$-57M

IMUX$-88M

EPS (TTM)

CADL-$1.19

IMUX-$2.62

ROE (TTM)

CADL-8938.0%

IMUX-9567.0%

ROA (TTM)

CADL-5631.0%

IMUX-10788.0%

ROIC (TTM)

CADL-6512.0%

IMUX-9567.0%

Cash

CADL$202M

IMUX$155M

Debt

CADL$48M

IMUX$0

Net Cash/Debt

CADL$154M

IMUX$155M

Current Ratio (TTM)

CADL16.09x

IMUX5.05x

Quick Ratio (TTM)

CADL15.89x

IMUX5.00x

Debt/Equity (TTM)

CADL0.38x

IMUX0.00x

Debt/Assets (TTM)

CADL0.0%

IMUX0.0%

Interest Coverage (TTM)

CADLN/A

IMUXN/A

Net Debt/EBITDA (TTM)

CADL0.00x

IMUX0.00x

Beta

CADL-0.28

IMUX1.47

52W Performance

CADL57.8%

IMUX-8.8%

YTD Performance

CADL82.7%

IMUX40.5%

% from 52W High

CADL-29.0%

IMUX-53.0%

% from 52W Low

CADL128.5%

IMUX61.9%

Asset Turnover (TTM)

CADL0.00x

IMUX0.00x

FCF Yield (TTM)

CADL-7.9%

IMUX-78.9%

Earnings Yield (TTM)

CADL-12.2%

IMUX-100.0%

Dividend Yield (TTM)

CADLN/A

IMUXN/A

Rule of 40

CADL0.0

IMUX0.0

EV/GP/RG

CADLN/A

IMUXN/A

Ticker research

View CADL research View IMUX research

Metric	CADL Candel Therapeutics Inc	IMUX Immunic Inc
Market & Valuation
Market Cap	$728M	$112M
Enterprise Value	$575M	$-44M
Price	$9.94	$8.19
P/E Ratio	N/A	N/A
P/S Ratio	6,281.93x	0.00x
EV/Sales	5,042.14x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.18x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.02x	0.49x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	371.1%	650.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-89M	$-112M
FCF (TTM)	$-57M	$-88M
EPS (TTM)	-$1.19	-$2.62
ROE (TTM)	-8938.0%	-9567.0%
ROA (TTM)	-5631.0%	-10788.0%
ROIC (TTM)	-6512.0%	-9567.0%
Financial Health
Cash	$202M	$155M
Debt	$48M	$0
Net Cash/Debt	$154M	$155M
Current Ratio (TTM)	16.09x	5.05x
Quick Ratio (TTM)	15.89x	5.00x
Debt/Equity (TTM)	0.38x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.28	1.47
52W Performance	57.8%	-8.8%
YTD Performance	82.7%	40.5%
% from 52W High	-29.0%	-53.0%
% from 52W Low	128.5%	61.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-7.9%	-78.9%
Earnings Yield (TTM)	-12.2%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CADL research	View IMUX research

Valuation

P/S Ratio

IMUX

0.00x

CADL

6,281.93x

EV/FCF

CADL

-10.02x

IMUX

0.49x

Growth & revenue

Forward Revenue Growth

IMUX

650.4%

CADL

371.1%

Profitability & performance

Gross Margin

CADL

0.0%

IMUX

0.0%

ROE

CADL

-8938.0%

IMUX

-9567.0%

FCF Yield %

CADL

-7.9%

IMUX

-78.9%

52-Week Performance

CADL

57.8%

IMUX

-8.8%

Detailed metrics comparison

CADL

Candel Therapeutics Inc

IMUX

Immunic Inc

Market Cap

CADL$728M

IMUX$112M

Enterprise Value

CADL$575M

IMUX$-44M

Price

CADL$9.94

IMUX$8.19

P/E Ratio

CADLN/A

IMUXN/A

P/S Ratio

CADL6,281.93x

IMUX0.00x

EV/Sales

CADL5,042.14x

IMUX0.00x

EV/EBITDA

CADL0.00x

IMUX0.00x

P/B Ratio

CADL6.18x

IMUX0.85x

P/FCF Ratio

CADLN/A

IMUXN/A

EV/FCF

CADL-10.02x

IMUX0.49x

PEG Ratio

CADLN/A

IMUXN/A

Forward P/E (NTM)

CADLN/A

IMUXN/A

Forward P/S (NTM)

CADLN/A

IMUXN/A

Revenue (TTM)

CADL$0

IMUX$0

Revenue Growth (YoY)

CADLN/A

IMUXN/A

Forward Rev Growth

CADL371.1%

IMUX650.4%

Gross Margin (TTM)

CADL0.0%

IMUX0.0%

Operating Margin (TTM)

CADL0.0%

IMUX0.0%

EBITDA Margin (TTM)

CADL0.0%

IMUX0.0%

Net Margin (TTM)

CADL0.0%

IMUX0.0%

FCF Margin (TTM)

CADLN/A

IMUXN/A

Net Income (TTM)

CADL$-89M

IMUX$-112M

FCF (TTM)

CADL$-57M

IMUX$-88M

EPS (TTM)

CADL-$1.19

IMUX-$2.62

ROE (TTM)

CADL-8938.0%

IMUX-9567.0%

ROA (TTM)

CADL-5631.0%

IMUX-10788.0%

ROIC (TTM)

CADL-6512.0%

IMUX-9567.0%

Cash

CADL$202M

IMUX$155M

Debt

CADL$48M

IMUX$0

Net Cash/Debt

CADL$154M

IMUX$155M

Current Ratio (TTM)

CADL16.09x

IMUX5.05x

Quick Ratio (TTM)

CADL15.89x

IMUX5.00x

Debt/Equity (TTM)

CADL0.38x

IMUX0.00x

Debt/Assets (TTM)

CADL0.0%

IMUX0.0%

Interest Coverage (TTM)

CADLN/A

IMUXN/A

Net Debt/EBITDA (TTM)

CADL0.00x

IMUX0.00x

Beta

CADL-0.28

IMUX1.47

52W Performance

CADL57.8%

IMUX-8.8%

YTD Performance

CADL82.7%

IMUX40.5%

% from 52W High

CADL-29.0%

IMUX-53.0%

% from 52W Low

CADL128.5%

IMUX61.9%

Asset Turnover (TTM)

CADL0.00x

IMUX0.00x

FCF Yield (TTM)

CADL-7.9%

IMUX-78.9%

Earnings Yield (TTM)

CADL-12.2%

IMUX-100.0%

Dividend Yield (TTM)

CADLN/A

IMUXN/A

Rule of 40

CADL0.0

IMUX0.0

EV/GP/RG

CADLN/A

IMUXN/A

Ticker research

View CADL research View IMUX research

Metric	CADL Candel Therapeutics Inc	IMUX Immunic Inc
Market & Valuation
Market Cap	$728M	$112M
Enterprise Value	$575M	$-44M
Price	$9.94	$8.19
P/E Ratio	N/A	N/A
P/S Ratio	6,281.93x	0.00x
EV/Sales	5,042.14x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.18x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.02x	0.49x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	371.1%	650.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-89M	$-112M
FCF (TTM)	$-57M	$-88M
EPS (TTM)	-$1.19	-$2.62
ROE (TTM)	-8938.0%	-9567.0%
ROA (TTM)	-5631.0%	-10788.0%
ROIC (TTM)	-6512.0%	-9567.0%
Financial Health
Cash	$202M	$155M
Debt	$48M	$0
Net Cash/Debt	$154M	$155M
Current Ratio (TTM)	16.09x	5.05x
Quick Ratio (TTM)	15.89x	5.00x
Debt/Equity (TTM)	0.38x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.28	1.47
52W Performance	57.8%	-8.8%
YTD Performance	82.7%	40.5%
% from 52W High	-29.0%	-53.0%
% from 52W Low	128.5%	61.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-7.9%	-78.9%
Earnings Yield (TTM)	-12.2%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CADL research	View IMUX research